1. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Frutos MJ, et al. Re-evaluation of konjac gum (E 425 i) and konjac glucomannan (E 425 ii) as food additives. EFSA J. 2017;15(6):4864. doi:10.2903/j.efsa.2017.4864.
2. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Oat beta-glucans and reduction of postprandial glucose peak: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J. 2026;24(2):9942. doi:10.2903/j.efsa.2026.9942.
3. Pokushalov E, Ponomarenko A, Garcia C, Pak I, Shrainer E, Seryakova M, et al. The impact of glucomannan, inulin, and psyllium supplementation (SolowaysTM) on weight loss in adults with FTO, LEP, LEPR, and MC4R polymorphisms: a randomized, double-blind, placebo-controlled trial. Nutrients. 2024;16(4):557. doi:10.3390/nu16040557.
4. Ghosh A, Mohol P, Ghosh S. Konjac glucomannan as an emerging nutritional strategy for obesity control via gut microbiota and metabolic regulation. Discover Food. 2025;5(1):222. doi:10.1007/s44187-025-00533-0.
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to konjac mannan (glucomannan) and reduction of body weight (ID 854, 1556, 3725), reduction of post-prandial glycaemic responses (ID 1559), maintenance of normal blood glucose concentrations (ID 835, 3724), maintenance of normal (fasting) blood concentrations of triglycerides (ID 3217), maintenance of normal blood cholesterol concentrations (ID 3100, 3217), maintenance of normal bowel function (ID 834, 1557, 3901) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1558) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2010;8(10):1798. doi:10.2903/j.efsa.2010.1798.
6. Yu Y, Jin S, Yang Y, Han X, Guan R, Zhong H. Interaction between konjac glucomannan and gut microbiota and its impact on health. Biology (Basel). 2025;14(8):923. doi:10.3390/biology14080923.
7. Medicines and Healthcare products Regulatory Agency. Over-the-counter stimulant laxatives: benefit-risk review. London: GOV.UK; 2020.
8. Chen HL, Cheng HC, Wu WT, Liu YJ, Liu SY. Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial. J Am Coll Nutr. 2008;27(1):102-8. doi:10.1080/07315724.2008.10719681.
9. Mirzababaei A, Zandkarimi R, Moradi S, Rasaei N, Amini MR, Pourreza S, et al. The effect of glucomannan on fasting and postprandial blood glucose in adults: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2022;21:1055-63. doi:10.1007/s40200-022-00993-6.
10. (Insufficient bibliographic data to format accurately from the provided link. DOI: 10.3746/pnf.2025.30.2.120)
11. Kuczora S. Authorised EU health claims for glucomannan, guar gum and hydroxypropyl methylcellulose. In: Foods, Nutrients and Food Ingredients with Authorised EU Health Claims. Cambridge (UK): Woodhead Publishing; 2015. p. 175-188. doi:10.1016/B978-1-78242-382-9.00010-4.
12. Drugs.com. Glucomannan uses, benefits & dosage. 2025 May 21.